Study S001890

Cardiovascular and Metabolic Effects of Drugs for the Treatment of Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04575194
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 40
Start: 2020-09-08
Primary completion: 2022-09-30
Lead sponsor: National and Kapodistrian University of Athens
Conditions: Obesity; Blood Pressure
Interventions: DRUG:Liraglutide 6 MG/ML [Saxenda]; DRUG:Naltrexone-Bupropion Combination
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Changes in blood pressure [3 and 6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.